Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial Evaluating GLIADEL Compared to Stereotactic Radiosurgery in Subjects With Metastatic Brain Disease

NCT04222062 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT04222062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04222062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial Evaluating GLIADEL Compared to Stereotactic Radiosurgery in Subjects With Metastatic Brain Disease
Lead sponsor
University of Nebraska
Phase
Phase 2
Overall status
Recruiting
Start date
November 6, 2020
Completion date
December 31, 2029
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor - metastatic